Assessment of a HER2 scoring system for gastric cancer: results from a validation study
Abstract
Aims: Human epidermal growth factor receptor 2 (HER2) overexpression/amplification is implicated in the development of various solid tumour types. Validated methods and scoring systems for evaluating HER2 status exist in breast cancer, but not in gastric cancer. The aim was to establish a HER2 scoring system for gastric cancer to identify suitable patients for enrolment in a trial of trastuzumab (Herceptin ® ) in advanced metastatic gastric...
Paper Details
Title
Assessment of a HER2 scoring system for gastric cancer: results from a validation study
Published Date
Apr 18, 2008
Journal
Volume
52
Issue
7
Pages
797 - 805
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History